The survival benefit of increasing the number of active drugs for metastatic colorectal cancer: A multicenter retrospective study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The survival benefit of increasing the number of active drugs for metastatic colorectal cancer: A multicenter retrospective study

Published:2022-02-19 Issue:11 Volume:11 Page:2184-2192
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Kawakami Takeshi¹^ORCID,Masuishi Toshiki²,Kawamoto Yasuyuki³,Go Hirofumi⁴^ORCID,Kato Kyoko²,Kumanishi Ryosuke²,Sawada Kentaro⁵⁶,Yuki Satoshi⁵,Yamamoto Kouji⁴,Komatsu Yoshito³,Muro Kei²^ORCID,Fushiki Kunihiro¹,Shirasu Hiromichi¹,Yamazaki Kentaro¹

Affiliation:

1. Department of Gastrointestinal Oncology Shizuoka Cancer Center Shizuoka Japan

2. Department of Clinical Oncology Aichi Cancer Center Hospital Nagoya Japan

3. Division of Cancer Center Hokkaido University Hospital Sapporo Japan

4. Department of Biostatistics Yokohama City University Yokohama Japan

5. Department of Gastroenterology and Hepatology Hokkaido University Hospital Sapporo Japan

6. Department of Medical Oncology Kushiro Rosai Hospital Kushiro Japan

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.4599

Reference23 articles.

1. The Global Cancer Observatory.https://gcoiarcfr/today/data/factsheets/cancers/10_8_9‐Colorectum‐fact‐sheetpdf

2. Critical Evaluation of Current Treatments in Metastatic Colorectal Cancer

3. Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid.

4. The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of biomarker in later-line treatment for metastatic colorectal cancer;Journal of Gastrointestinal Oncology;2023-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3